Federal State Unitary Enterprise (FSUE) St. Petersburg Scientific Research Institute of Vaccines and Serums and Biopharmaceutical Plant under Federal Medical Biological Agency of Russia has been conducting research and development and producing preventive, diagnostic, and therapeutic medications for more than 120 years. SPbSRIVS has highly skilled research and production staff and uses state-of-the-art technology to offer products that meet all existing global standards. SPbSRIVS is a major supplier of therapeutic, preventive, and diagnostic medications to the markets in Russia and the CIS.
Our key products are vaccines against influenza and herpes, tuberculosis allergen (tuberculin), preparations used in the diagnosis of tuberculosis, syphilis, intestinal and coccal infections, forensic serums. Some of the most important medications that we produce are:
The last three years have witnessed an increase in the value of government contracts won by SPbSRIVS from 200 mln rubles in 2012 to 680 mln rubles in 2015 and a more than fourfold increase in the sales revenue. This revenue growth was made possible by the adoption of new technology and a complete upgrade of the immunobiological production line, which was done on a tight schedule, due to existing obligations under government contracts.